Komamura H, Higashiyama M, Hashimoto K, Takeda K, Kimura H, Tani Y, Ogawa H, Yoshikawa K
Department of Dermatology, Osaka University School of Medicine, Japan.
J Dermatol. 1995 Feb;22(2):116-21. doi: 10.1111/j.1346-8138.1995.tb03354.x.
Three cases of chemotherapy-induced acral erythema are reported. All the patients had received cyclophosphamide, vincristine, adriamycin, prednisolone, and granulocyte-colony stimulating factor (G-CSF) for the treatment of leukemia or malignant lymphoma. From 35 to 45 days after the start of chemotherapy, painful erythematous lesions developed on their palms, soles, fingers, and toes, resulting in blister formation and desquamation. The recent higher incidence of chemotherapy-induced acral erythema may be correlated with the popularity of G-CSF, which allows the use of higher doses of chemotherapeutic drugs.
